DE-ESCALATION OF BREAST CANCER TREATMENTS ORGANISED BY EORTC AND BIG
Time Zone:
Europe/Paris GMT+2
Institution:
EORTC, BIG
previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Moderator:
Speakers:
Theme :
Language:
Etienne Brain, David Cameron, Boon Chua, Fatima Cardoso, Elizabeth Bergsten Nordstrom
Brief introduction on global breast cancer research and de-escalation of breast cancer treatments, Brief presentation of DECRESCENDO study and introduction of the speakers, Tailoring radio therapy after surgery to an individual patient’s risk of recurrence (EXPERT study – BIG Radio Tuning). Tailoring radiation dose escalation after surgery: cosmetic results and patient reported outcomes informing treatment decision-making (DCIS study), Using the biological characteristics of a tumour and novel diagnostic tests to help safely exclude chemotherapy (MINDACT study), Getting the patient’s perspective: Importance of giving patients the right information about de-escalation risks, Q&A session
Inglês
Programme
13:00-13:05 Brief introduction on global breast cancer research and de-escalation of breast cancer treatments – Prof. Etienne Brain, EORTC Breast Cancer Group Chair & BIG Executive Board member
13:05-13:10 Brief presentation of DECRESCENDO study and introduction of the speakers – Prof. David Cameron, BIG Chair and EORTC Breast Cancer Group member
13:10-13:25 Tailoring radio therapy after surgery to an individual patient’s risk of recurrence (EXPERT study – BIG Radio Tuning). Tailoring radiation dose escalation after surgery: cosmetic results and patient reported outcomes informing treatment decision-making (DCIS study) – Prof. Boon Chua, BIG Executive Board member & Study Principal Investigator of EXPERT and DCIS
13:25-13:35 Using the biological characteristics of a tumour and novel diagnostic tests to help safely exclude chemotherapy (MINDACT study) – Prof. Fatima Cardoso, EORTC Breast Cancer Group and BIG member & Study Principal Investigator of MINDACT
13:35-13:45 Getting the patient’s perspective: Importance of giving patients the right information about de-escalation risks – Mrs Elizabeth Bergsten Nordstrom, EUROPA DONNA Executive Board member
13:45-14:00 Q&A session